ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SPRC SciSparc Ltd

1.2196
-0.0004 (-0.03%)
Last Updated: 11:03:18
Delayed by 15 minutes

Period:

Draw Mode:

Volume 17,875
Bid Price 1.20
Ask Price 1.22
News -
Day High 1.23

Low
1.15

52 Week Range

High
23.66

Day Low 1.20
Company Name Stock Ticker Symbol Market Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0004 -0.03% 1.2196 11:03:18
Open Price Low Price High Price Close Price Prev Close
1.20 1.20 1.23 1.22
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
80 17,875 $ 1.21 $ 21,642 - 1.15 - 23.66
Last Trade Time Type Quantity Stock Price Currency
11:03:18 1,367 $ 1.2196 USD

SciSparc Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
635.73k 521.09k - 2.88M -5.12M -9.83 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SciSparc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SPRC Message Board. Create One! See More Posts on SPRC Message Board See More Message Board Posts

Historical SPRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.271.291.191.2279,906-0.0504-3.97%
1 Month1.241.441.151.28105,474-0.0204-1.65%
3 Months3.714.28611.152.28626,705-2.49-67.13%
6 Months6.4714.21991.155.561,056,869-5.25-81.15%
1 Year15.953623.661.155.921,926,325-14.73-92.36%
3 Years182.00184.081.1519.251,474,502-180.78-99.33%
5 Years182.00184.081.1519.251,474,502-180.78-99.33%

SciSparc Description

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

Your Recent History

Delayed Upgrade Clock